Baird Downgrades Doximity to Neutral, Lowers Price Target to $18

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

Baird analyst Vikram Kesavabhotla downgrades Doximity (NYSE: DOCS) from Outperform to Neutral and lowers the price target from $40 to $18.